LPTX
Price
$0.36
Change
+$0.01 (+2.86%)
Updated
Jul 23 closing price
Capitalization
14.8M
TECX
Price
$22.95
Change
+$0.73 (+3.29%)
Updated
Jul 23, 04:59 PM (EDT)
Capitalization
414.9M
Interact to see
Advertisement

LPTX vs TECX

Header iconLPTX vs TECX Comparison
Open Charts LPTX vs TECXBanner chart's image
Leap Therapeutics
Price$0.36
Change+$0.01 (+2.86%)
Volume$368.48K
Capitalization14.8M
Tectonic Therapeutic
Price$22.95
Change+$0.73 (+3.29%)
Volume$1.66K
Capitalization414.9M
LPTX vs TECX Comparison Chart in %
Loading...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LPTX vs. TECX commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPTX is a Hold and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (LPTX: $0.36 vs. TECX: $22.92)
Brand notoriety: LPTX and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPTX: 22% vs. TECX: 83%
Market capitalization -- LPTX: $14.8M vs. TECX: $427.97M
LPTX [@Biotechnology] is valued at $14.8M. TECX’s [@Biotechnology] market capitalization is $427.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.06B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPTX’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • LPTX’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, TECX is a better buy in the long-term than LPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPTX’s TA Score shows that 6 TA indicator(s) are bullish while TECX’s TA Score has 6 bullish TA indicator(s).

  • LPTX’s TA Score: 6 bullish, 4 bearish.
  • TECX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TECX is a better buy in the short-term than LPTX.

Price Growth

LPTX (@Biotechnology) experienced а +2.06% price change this week, while TECX (@Biotechnology) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.15%. For the same industry, the average monthly price growth was +22.17%, and the average quarterly price growth was +31.45%.

Reported Earning Dates

LPTX is expected to report earnings on May 13, 2025.

TECX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+8.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($415M) has a higher market cap than LPTX($14.8M). TECX YTD gains are higher at: -52.523 vs. LPTX (-87.576). TECX has higher annual earnings (EBITDA): -56.94M vs. LPTX (-71.67M). TECX has more cash in the bank: 306M vs. LPTX (32.7M). LPTX has less debt than TECX: LPTX (154K) vs TECX (2.63M). LPTX (0) and TECX (0) have equivalent revenues.
LPTXTECXLPTX / TECX
Capitalization14.8M415M4%
EBITDA-71.67M-56.94M126%
Gain YTD-87.576-52.523167%
P/E RatioN/AN/A-
Revenue00-
Total Cash32.7M306M11%
Total Debt154K2.63M6%
FUNDAMENTALS RATINGS
LPTX vs TECX: Fundamental Ratings
LPTX
TECX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
9354
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (21) in the null industry is in the same range as LPTX (37) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as LPTX (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's SMR Rating (94) in the null industry is in the same range as LPTX (99) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECX's Price Growth Rating (54) in the null industry is somewhat better than the same rating for LPTX (93) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than LPTX’s over the last 12 months.

TECX's P/E Growth Rating (100) in the null industry is in the same range as LPTX (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to LPTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LPTXTECX
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMFPF23.85N/A
N/A
Amplifon S.p.A.
CBGPY11.05N/A
N/A
Close Brothers Group Plc
AZNCF139.70-2.32
-1.63%
AstraZeneca Plc
DCMDF1.25-0.03
-2.42%
Data Communications Management Corp.
CLOW0.03N/A
-4.73%
Cloudweb, Inc.

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+0.05%
IGC - TECX
49%
Loosely correlated
+3.06%
LPTX - TECX
38%
Loosely correlated
-1.45%
ATHE - TECX
37%
Loosely correlated
-2.00%
IMNM - TECX
36%
Loosely correlated
+2.27%
SRPT - TECX
35%
Loosely correlated
-5.36%
More